Weight loss drug maker sinks 25% after new safety data spooks investors
- Posted on June 8, 2026
- By CNBC
- 1 Views
- 1 min read
Weight loss drug maker sinks 25% after new safety data spooks investors
While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.
